Cargando…

Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)

BACKGROUND: Acinetobacter calcoaceticus–A. baumannii (Acb) complex and Stenotrophomonas maltophilia represent frequent causes of hospital-acquired infections. We evaluated the frequency and resistance rates of Acb complex and S. maltophilia isolates from medical centers enrolled in the SENTRY Progra...

Descripción completa

Detalles Bibliográficos
Autores principales: Gales, Ana C, Seifert, Harald, Gur, Deniz, Castanheira, Mariana, Jones, Ronald N, Sader, Helio S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419908/
https://www.ncbi.nlm.nih.gov/pubmed/30895213
http://dx.doi.org/10.1093/ofid/ofy293
_version_ 1783404023406133248
author Gales, Ana C
Seifert, Harald
Gur, Deniz
Castanheira, Mariana
Jones, Ronald N
Sader, Helio S
author_facet Gales, Ana C
Seifert, Harald
Gur, Deniz
Castanheira, Mariana
Jones, Ronald N
Sader, Helio S
author_sort Gales, Ana C
collection PubMed
description BACKGROUND: Acinetobacter calcoaceticus–A. baumannii (Acb) complex and Stenotrophomonas maltophilia represent frequent causes of hospital-acquired infections. We evaluated the frequency and resistance rates of Acb complex and S. maltophilia isolates from medical centers enrolled in the SENTRY Program. METHODS: A total of 13 752 Acb complex and 6467 S. maltophilia isolates were forwarded to a monitoring laboratory by 259 participating sites from the Asia-Pacific region, Latin America, Europe, and North America between 1997 and 2016. Confirmation of species identification and antimicrobial susceptibility testing were performed using conventional methods and/or matrix-assisted laser desorption ionization–time of flight mass spectrometry and the broth microdilution method, respectively. Antimicrobial susceptibility results were interpreted by CLSI and EUCAST 2018 criteria. RESULTS: Acb complex and S. maltophilia were most frequently isolated from patients hospitalized with pneumonia (42.9% and 55.8%, respectively) and bloodstream infections (37.3% and 33.8%, respectively). Colistin and minocycline were the most active agents against Acb complex (colistin MIC(50/90), ≤0.5/2 mg/L; 95.9% susceptible) and S. maltophilia (minocycline MIC(50/90), ≤1/2 mg/L; 99.5% susceptible) isolates, respectively. Important temporal decreases in susceptibility rates among Acb complex isolates were observed for all antimicrobial agents in all regions. Rates of extensively drug-resistant Acb complex rates were highest in Europe (66.4%), followed by Latin America (61.5%), Asia-Pacific (56.9%), and North America (38.8%). Among S. maltophilia isolates, overall trimethoprim-sulfamethoxazole (TMP-SMX) susceptibility rates decreased from 97.2% in 2001–2004 to 95.7% in 2013–2016, but varied according to the geographic region. CONCLUSIONS: We observed important reductions of susceptibility rates to all antimicrobial agents among Acb complex isolates obtained from all geographic regions. In contrast, resistance rates to TMP-SMX among S. maltophilia isolates remained low and relatively stable during the study period.
format Online
Article
Text
id pubmed-6419908
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-64199082019-03-20 Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016) Gales, Ana C Seifert, Harald Gur, Deniz Castanheira, Mariana Jones, Ronald N Sader, Helio S Open Forum Infect Dis Supplement Article BACKGROUND: Acinetobacter calcoaceticus–A. baumannii (Acb) complex and Stenotrophomonas maltophilia represent frequent causes of hospital-acquired infections. We evaluated the frequency and resistance rates of Acb complex and S. maltophilia isolates from medical centers enrolled in the SENTRY Program. METHODS: A total of 13 752 Acb complex and 6467 S. maltophilia isolates were forwarded to a monitoring laboratory by 259 participating sites from the Asia-Pacific region, Latin America, Europe, and North America between 1997 and 2016. Confirmation of species identification and antimicrobial susceptibility testing were performed using conventional methods and/or matrix-assisted laser desorption ionization–time of flight mass spectrometry and the broth microdilution method, respectively. Antimicrobial susceptibility results were interpreted by CLSI and EUCAST 2018 criteria. RESULTS: Acb complex and S. maltophilia were most frequently isolated from patients hospitalized with pneumonia (42.9% and 55.8%, respectively) and bloodstream infections (37.3% and 33.8%, respectively). Colistin and minocycline were the most active agents against Acb complex (colistin MIC(50/90), ≤0.5/2 mg/L; 95.9% susceptible) and S. maltophilia (minocycline MIC(50/90), ≤1/2 mg/L; 99.5% susceptible) isolates, respectively. Important temporal decreases in susceptibility rates among Acb complex isolates were observed for all antimicrobial agents in all regions. Rates of extensively drug-resistant Acb complex rates were highest in Europe (66.4%), followed by Latin America (61.5%), Asia-Pacific (56.9%), and North America (38.8%). Among S. maltophilia isolates, overall trimethoprim-sulfamethoxazole (TMP-SMX) susceptibility rates decreased from 97.2% in 2001–2004 to 95.7% in 2013–2016, but varied according to the geographic region. CONCLUSIONS: We observed important reductions of susceptibility rates to all antimicrobial agents among Acb complex isolates obtained from all geographic regions. In contrast, resistance rates to TMP-SMX among S. maltophilia isolates remained low and relatively stable during the study period. Oxford University Press 2019-03-15 /pmc/articles/PMC6419908/ /pubmed/30895213 http://dx.doi.org/10.1093/ofid/ofy293 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Supplement Article
Gales, Ana C
Seifert, Harald
Gur, Deniz
Castanheira, Mariana
Jones, Ronald N
Sader, Helio S
Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
title Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
title_full Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
title_fullStr Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
title_full_unstemmed Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
title_short Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
title_sort antimicrobial susceptibility of acinetobacter calcoaceticus–acinetobacter baumannii complex and stenotrophomonas maltophilia clinical isolates: results from the sentry antimicrobial surveillance program (1997–2016)
topic Supplement Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419908/
https://www.ncbi.nlm.nih.gov/pubmed/30895213
http://dx.doi.org/10.1093/ofid/ofy293
work_keys_str_mv AT galesanac antimicrobialsusceptibilityofacinetobactercalcoaceticusacinetobacterbaumanniicomplexandstenotrophomonasmaltophiliaclinicalisolatesresultsfromthesentryantimicrobialsurveillanceprogram19972016
AT seifertharald antimicrobialsusceptibilityofacinetobactercalcoaceticusacinetobacterbaumanniicomplexandstenotrophomonasmaltophiliaclinicalisolatesresultsfromthesentryantimicrobialsurveillanceprogram19972016
AT gurdeniz antimicrobialsusceptibilityofacinetobactercalcoaceticusacinetobacterbaumanniicomplexandstenotrophomonasmaltophiliaclinicalisolatesresultsfromthesentryantimicrobialsurveillanceprogram19972016
AT castanheiramariana antimicrobialsusceptibilityofacinetobactercalcoaceticusacinetobacterbaumanniicomplexandstenotrophomonasmaltophiliaclinicalisolatesresultsfromthesentryantimicrobialsurveillanceprogram19972016
AT jonesronaldn antimicrobialsusceptibilityofacinetobactercalcoaceticusacinetobacterbaumanniicomplexandstenotrophomonasmaltophiliaclinicalisolatesresultsfromthesentryantimicrobialsurveillanceprogram19972016
AT saderhelios antimicrobialsusceptibilityofacinetobactercalcoaceticusacinetobacterbaumanniicomplexandstenotrophomonasmaltophiliaclinicalisolatesresultsfromthesentryantimicrobialsurveillanceprogram19972016